Benzinga | Oct 14, 2021 07:08AM EDT

Redburn Partners Initiates Coverage On Abbott Laboratories with Neutral Rating

Redburn Partners analyst Simon Baker initiates coverage on Abbott Laboratories (NYSE:ABT) with a Neutral rating.